Abstract
Neuroendocrine carcinoma (NEC) are tumors affecting lungs in the first line. Extra-pulmonary locations are rare, and involvement of the oral cavity is uncommon. The therapeutic strategy of this clinically aggressive entity is not codified. Nevertheless, multimodal treatment combining surgery and radio-chemotherapy is associated with the best results in terms of local control and overall survival. We report a case of a 67-year-old patient, diagnosed with a NEC, the computed tomography (CT) of the facial mass objectified a jugal mass of 2x2.4 cm with two lymph nodes. The patient benefited from an excisional biopsy of the mass, and whose histological examination and immunohistochemical testing returned in favor of a small cell neuroendocrine carcinoma.
Publisher
Mapsci Digital Publisher OPC Pvt. Ltd.
Reference21 articles.
1. 1. Haider K, Shahid RK, Finch D, Sami A, Ahmad I, Yadav S, et al. Extrapulmonary small cell cancer: a Canadian province's experience. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2006;107(9):2262-9. PubMed | CrossRef
2. 2. Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15(3):264-78. PubMed | CrossRef
3. 3. Perez-Ordonez B, Bishop JA, Gnepp DR. Neuroendocrine tumors. In: El-Naggar AK, Chan JK, Grandis JR. WHO classification of head and neck tumours. 2017:95-8.
4. 4. Kusafuka K, Ferlito A, Lewis Jr JS, Woolgar JA, Rinaldo A, Slootweg PJ, et al. Large cell neuroendocrine carcinoma of the head and neck. Oral Oncol. 2012;48(3):211-5. PubMed | CrossRef
5. 5. Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13(12):1255. PubMed | CrossRef